BioSig’s Bold Shift: From Medical Tech to Digital Gold
BioSig Technologies, a company once solely focused on medical innovations, is making a dramatic pivot into the world of blockchain and asset tokenization. With a $1.1 billion funding commitment from an undisclosed investor, BioSig is now gearing up to digitally tokenize gold and build a gold-backed treasury—a major move that could redefine its market position.
Massive Funding Fuels the Transition
The funding will arrive in two parts:
- $100 million in senior secured convertible notes, and
- $1 million in an equity-backed credit facility.
The convertible notes, priced at $0.96 per $1, will mature in 24 months, paying a 4% annual interest rate—which could jump to 18% in the event of default. These notes can be converted into common stock, offering flexibility for both the company and the investor. Meanwhile, the credit facility gives BioSig the option to sell stock to the investor over a 36-month period.
Merger with Streamex Sets the Stage
This pivot follows BioSig’s recent merger with Streamex Exchange Corporation, a company that specializes in bringing real-world assets (RWA) like gold on-chain. Streamex’s core mission is to expand investor access and optimize asset liquidity by tokenizing traditionally illiquid commodities. The merger has effectively transformed BioSig from a med-tech firm into a hybrid fintech innovator.
With its new partner, BioSig plans to launch a gold-backed digital treasury, making it possible to tokenize and trade gold seamlessly within blockchain ecosystems.
October 2025: Key Milestone Ahead
The first funding tranche—$75 million in notes—and the activation of the credit facility are scheduled for October 7, 2025, pending shareholder approval under Nasdaq regulations. A second tranche of $25 million will be released upon completion of other regulatory conditions.
Big Names, Bigger Expectations
Heavyweights like Tether, Cantor Fitzgerald, and Clear Street are backing BioSig’s fundraising and asset placement, signaling industry confidence in the company’s ambitious shift. Following the announcement, BSGM stock surged by 30%, demonstrating market enthusiasm for the project.
Conclusion: BioSig Bets on Blockchain’s Future
BioSig’s $1.1 billion raise to tokenize gold and launch a blockchain-based treasury isn’t just a financial milestone—it’s a strategic leap. By leveraging Streamex’s on-chain infrastructure and tapping into gold’s enduring value, the company positions itself at the intersection of fintech, DeFi, and real-world asset management. If executed well, this move could set a new standard for how legacy companies reinvent themselves through blockchain innovation.
